Valiant Organics is a specialty chemicals maker that turns basic building blocks into the intermediates other industries cannot do without - the molecules that go into paracetamol tablets, hair dyes, crop protection sprays and veterinary medicines. It was founded in 1984 by first-generation technocrats as a single-product partnership, grew into a public company within the Aarti Group fold, and built its position by acquiring chemistry capabilities it did not originally have - ammonolysis in 2017, hydrogenation and sulphonation in 2019 - so that today it runs six plants across five chemistries. The recurring approach is simple: find a niche intermediate that India imports heavily, master the difficult chemistry behind it, then scale to a size that lets it compete with Chinese producers on cost while locking in customers through long-term contracts - roughly 60% of its operations run on monthly, quarterly or half-yearly agreements. # Business segments Three chemistry engines, each built around a different set of reactions - a chlorophenol export franchise with a quarter of the global market, a hydrogenation platform that feeds the paracetamol supply chain, and an ammonolysis business that supplies nearly every major dye maker in the country. ## 1. Hydrogenation and methoxylation: the largest engine, anchored to paracetamol **This is where the company makes the intermediates that become painkillers, dyes and pigments - and it is the only domestic producer of several of them.** - **The paracetamol connection** - the Jhagadia Unit 2 plant makes Para Amino Phenol (PAP), the essential raw material for paracetamol synthesis, a difficult product that India previously imported; the company was among the first to commercialise it domestically in FY21 and sells the majority of its output to Valiant Laboratories Limited, which makes the finished paracetamol. - **Backward-integrated into its own raw materials** - Jhagadia Unit 1 produces Ortho Nitro Anisole and Para Nitro Anisole, which are captively consumed to make Ortho Anisidine and Para Anisidine, so the company does not need to buy these precursors from anyone else. - **One of very few players** - the company is among a handful of commercial manufacturers globally of Ortho Anisidine and Para Anisidine, which go into dyes, pigments and agrochemicals, giving it pricing power in a concentrated market. - **Green chemistry as a cost lever** - the hydrogenation process uses hydrogen gas and produces zero pollution, while high-pressure steam from manufacturing is converted into power for the plant, cutting the energy bill. - **Contract manufacturing fills the tanks** - the hydrogenation plants also run customised production for leading domestic clients, which means the assets earn even when the company's own products are not being made. ## 2. Chlorination and chlorophenol derivatives: the global-scale export franchise **The company is the only chlorophenol producer in India and holds roughly a quarter of the world market - a position built on scale that Chinese rivals cannot match.** - **Bigger than the Chinese** - Valiant's chlorophenol capacity is 1,800 tonnes per month, but they can operate at a maximum of 1,500-1,600 tonnes per month, while the largest Chinese competitors operate at around 1,000-1,200 tonnes per month, so the company can compete on cost and still serve global demand. - **A portfolio made from one reaction** - the chlorination plant at Sarigam produces five derivatives - Para ChloroPhenol, Ortho ChloroPhenol, 2,4 Di Chlorophenol, 2,6 Di ChloroPhenol and 2,4,6 Tri ChloroPhenol - that go into agrochemicals, cosmetics, veterinary drugs and pharmaceuticals. - **Exports are the majority** - more than half of chlorination sales go to export markets, and the company has long-term relationships with global marquee customers built on consistent quality and reliable supply. - **Waste turned into revenue** - 2,4,6 Tri ChloroPhenol was once a byproduct that had to be disposed of; the company developed a process to make it a marketable product, extracting value from what was previously a cost. ## 3. Ammonolysis: the dye-industry supplier with a raw-material edge **The company is one of India's largest makers of Para Nitro Aniline, the intermediate that gives dyes their colour - and it gets its key raw material from within the family.** - **Raw material security from the group** - the critical input for Para Nitro Aniline (PNA) is Para Nitro Chloro Benzene (PNCB), which is supplied by Aarti Industries, a fellow Aarti Group company, so Valiant is not exposed to the open market for its most important feedstock. - **Sells to every major dye maker** - the company supplies its ammonolysis products - PNA and Ortho Chloro Para Nitro Aniline - to almost all leading dye manufacturers in India, making it a default supplier to the domestic dyes and pigments industry. - **Two plants, one chemistry** - the Vapi and Tarapur facilities together give the company 16,600 tonnes per annum of ammonolysis capacity, making it one of the largest domestic players in this niche. # Group structure and partners **Valiant Organics sits inside the Aarti Group ecosystem, where roughly 40% of what it makes goes to group companies and roughly 40% of what it buys comes from them - a closed loop that locks in demand and supply.** - **A prominent Group company is both customer and supplier** - around 40% of Valiant's production is marketed to a prominent group company, and around 40% of its raw materials are sourced from that same entity, all at arm's length. - **The paracetamol chain stays in the family** - more than 85% of PAP output is sold to Valiant Laboratories Limited for paracetamol manufacture, and four of the five principal raw materials are procured from within the group. - **A stake that is being simplified** - Valiant held an indirect stake in Valiant Laboratories Limited through Dhanvallabh Ventures LLP; in May 2026 the board approved ceasing to be a partner of DVLLP and disposing of its partnership interest, simplifying the holding structure. - **Captive solar on the way** - in April 2025 the company agreed to subscribe to a 26.25% stake in a special-purpose vehicle that will build a solar power project, with the electricity supplied to Valiant for its own consumption, reducing its reliance on grid power.